Archive

Neovasc Announces Partial Prepayment of Convertible Debenture

Posted on August 17, 2020
in
by admin@neovasc.com

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, – August 17, 2020 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 501,000 of the remaining 1,149,910 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities...

Read More

Neovasc Announces Second Quarter Financial Results

Posted on August 6, 2020
in
by admin@neovasc.com

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, August 6, 2020 – Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies, and minimally invasive devices for the treatment of refractory angina, today reported financial results for...

Read More

Neovasc Announces Partial Prepayment of Convertible Debenture

Posted on July 23, 2020
in
by admin@neovasc.com

NASDAQ, TSX: NVCN   VANCOUVER and MINNEAPOLIS, – July 23, 2020 – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 1,424,049 of the 2,573,959 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase...

Read More